Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 526-539
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.526
Figure 1
Figure 1 Boolean analysis. A and B: Flow cytometry analysis for the identification of cellular populations using monoclonal antibodies CD45; C: VEGFR2; D: CD34; E: CD133. In all samples, the CD34 expression was weak. CPET: Cardiopulmonary exercise testing; VEGFR2: Vascular endothelial growth factor receptor 2.